13,093 results match your criteria: "Factor IX"

Extending the post-thaw shelf-life of cryoprecipitate when stored at refrigerated temperatures.

Vox Sang

December 2024

Research and Development, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia.

Article Synopsis
  • The study investigates the storage of thawed cryoprecipitate at 1-6°C to potentially extend its shelf-life beyond the current 6-hour limit, which leads to high wastage.
  • Over a 14-day period, various coagulation factors were monitored in mini- and full-size cryoprecipitate packs from apheresis and whole blood collections.
  • Results showed that while Factor VIII levels decreased significantly after 24 hours, most samples still met quality specifications up to 14 days post-thaw, indicating that refrigerated storage could be a viable solution.
View Article and Find Full Text PDF
Article Synopsis
  • - A 5-year-old girl with severe hemophilia B started having frequent muscle and joint bleeds at 19 months old.
  • - Genetic testing identified a mutation in the factor IX gene, as well as a large deletion in the Xq28 region, which is crucial for her condition.
  • - These findings not only clarify the severity of her hemophilia but also assist in family planning discussions for her family.
View Article and Find Full Text PDF
Article Synopsis
  • Patients with hemophilia B receive factor IX concentrates to prevent bleeding, and new extended half-life (EHL) options allow for less frequent dosing compared to standard treatments.
  • The recombinant FIX-Fc fusion protein (rFIXFc) is highlighted for its rapid distribution, potentially due to its binding to type IV collagen in the body, which may help prevent bleeding even when FIX activity is not measurable in plasma.
  • A physiologically based pharmacokinetic (PBPK) model accurately predicts how rFIXFc behaves in the body, showing significantly higher concentrations of the drug in the extravascular space compared to plasma, indicating its crucial role in achieving effective bleeding control after treatment.
View Article and Find Full Text PDF

Arterial Thrombosis: Present and Future.

Circulation

September 2024

Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University; and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.

View Article and Find Full Text PDF
Article Synopsis
  • Tea plants are important crops that produce chlorophyll, which is vital for their color and ability to photosynthesize effectively.
  • A study was conducted using high-throughput transcriptomic analysis to examine how different light conditions affect chlorophyll metabolism in tea plants.
  • The findings showed that light exposure influences the expression of key genes involved in chlorophyll synthesis, highlighting distinct patterns under continuous light and varied photoperiods.
View Article and Find Full Text PDF

Background: This study aimed to conduct molecular diagnostics among individuals with hemophilia B (HB) and carriers of hemophilia in Mongolia.

Methods: Eight patients (six severe, two mild) with HB and their 12 female relatives were enrolled from eight families. Sanger sequence was performed for mutation identification.

View Article and Find Full Text PDF

Clinical validation and application of targeted long-range polymerase chain reaction and long-read sequencing-based analysis for hemophilia: experience from a hemophilia treatment center in China.

J Thromb Haemost

December 2024

Center for Medical Genetics and Genomics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China; The Guangxi Health Commission Key Laboratory of Medical Genetics and Genomics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China; The Second School of Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China. Electronic address:

Background: Targeted long-read sequencing (LRS) is expected to comprehensively analyze diverse complex variants in hemophilia A (HA) and hemophilia B (HB) caused by the F8 and F9 genes, respectively. However, its clinical applicability still requires extensive validation.

Objectives: To evaluate the clinical applicability of targeted LRS-based analysis compared with routine polymerase chain reaction (PCR)-based methods.

View Article and Find Full Text PDF

Halide Mixing in CsAgBi(I Br ) Double Perovskites: A Pathway to Tunable Excitonic Properties.

J Phys Chem C Nanomater Interfaces

September 2024

MESA+ Institute for Nanotechnology, University of Twente, 7500 AE Enschede, The Netherlands.

Article Synopsis
  • CsAgBiBr is a promising semiconductor but has limitations for solar cell use due to its indirect band gap and localized electronic structure.
  • Recent research on CsAgBi(I, Br) nanocrystals shows that mixing halides significantly alters the electronic properties and optical excitations, enhancing exciton behavior.
  • The study confirms that up to 11% iodide can be mixed into the bulk material using mechanosynthesis, leading to a red-shifted absorption that aligns with theoretical predictions.
View Article and Find Full Text PDF
Article Synopsis
  • Hemophilia is caused by a deficiency in factor VIII or IX, which disrupts the coagulation pathway needed for blood clotting.
  • Researchers hypothesized that directly introducing activated FXa could restore normal coagulation in hemophilia patients.
  • In a study, an engineered AAV capsid successfully delivered FXa, showing effective hemostatic results and reducing bleeding and joint inflammation in hemophilia A and B mice, indicating its potential as a new treatment approach.
View Article and Find Full Text PDF

Squamous Cell Carcinoma (SCC) is a subtype of Non-Melanoma Skin Cancer, the most common group of malignancies worldwide. Photodynamic therapy (PDT) is a non-invasive treatment approved for specific subtypes of SCC. Some malignancies resist PDT, forming more aggressive tumors and multiple relapses.

View Article and Find Full Text PDF

Hemophilia and Other Congenital Coagulopathies in Women.

J Hematol

August 2024

Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine of Northwestern University, Chicago, IL 60611, USA. Email:

Deficiencies of factor VIII (FVIII)/von Willebrand factor (VWF) or factor IX (FIX) are underappreciated as potential reasons for heavy menstrual bleeding, recurrent nosebleeds, and easy bruising in girls and women. Bleeding is usually not attributed to hemophilia because clinically significant deficiencies in clotting factors VIII and IX are thought to only affect males. While severe hemophilia is more commonly observed in boys and men, women with mutations in the FVIII or FIX genes ( or may have widespread bruising and even joint bleeding.

View Article and Find Full Text PDF

An important aspect of improving care for people with hemophilia B (HB) is developing optimal treatment strategies. Here we aimed to provide in-silico evidence, comparing the estimated optimal posology of factor IX (FIX) products to support the patient-physician decision-making process. A population pharmacokinetic (popPK) model-based assessment comparing the performance of FIX products (rFIX, rIX-FP, rFIXFc, N9-GP) was developed.

View Article and Find Full Text PDF

Introduction: The prolongation in APTT reflects various disorders affecting the blood coagulation system. Automated coagulation analyzers such as ACL TOP, help in evaluating the clotting cascade by displaying clot reaction curves or waveforms. The fibrin formation curve forms S-shaped curve showing the changes in the absorbance on X-axis and time in seconds on Y-axis.

View Article and Find Full Text PDF

Coagulation factors VIII and factors IX testing practices in China: Results of the 5-year external quality assessment program.

Clin Chim Acta

January 2025

National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/ National Center of Gerontology, PR China. Electronic address:

Article Synopsis
  • The study assessed the performance of Chinese laboratories in testing coagulation factors VIII (FVIII) and IX (FIX) via a national external quality assessment scheme (China NEQAS) over five years (2019-2023).
  • Results showed a consistent decrease in the inter-laboratory coefficient of variation (CV) and an increase in pass rates for FVIII and FIX testing, indicating improved testing quality across laboratories.
  • The study concluded that external quality assessments have positively impacted testing accuracy, and suggested using chromogenic assays or dilution tests for better identification of inhibitors when needed.
View Article and Find Full Text PDF

[Hemophilia: is a revolution in treatment options taking place?].

Inn Med (Heidelb)

October 2024

INSTAND e. V. Düsseldorf Gesellschaft zur Förderung der Qualitätssicherung in med. Laboratorien, Ubierstr 20, 40223, Düsseldorf, Deutschland.

Prophylactic replacement therapy for hemophilia A (hereditary factor VIII deficiency) is a success story of the production of coagulation factor concentrates from donor plasma. Recombinant factor concentrates, which are also produced with modified gene constructs for coagulation factor VIII in order to improve pharmacological properties, have since proven their worth. This successful development over many years of factor concentrates for the successful treatment of hemophilia patients has now been followed by the innovation of a factor VIII mimetic in the form of a monoclonal antibody, which was developed in Japan already some years back.

View Article and Find Full Text PDF

[Not Available].

MMW Fortschr Med

September 2024

Freier Medizinjournalist, Rückerstraße 7, 10119, Berlin, Germany.

View Article and Find Full Text PDF

Lymphedema, hydrocele, and acute adenolymphangitis (ADL) are chronically disabling consequences in patients with lymphatic filariasis (LF). Provision of morbidity management and disability prevention and concurrent mass drug administration of anthelmintics are two pillars for elimination of LF. This study assessed the impact of strict hygiene protocols with or without doxycycline on the progression of filarial lymphedema.

View Article and Find Full Text PDF

Treatment-resistant depression (TRD) occurs in almost 50% of the depressed patients. Central kappa opioid receptor (KOR) agonism has been demonstrated to induce depression and anxiety, while KOR antagonism alleviates depression-like symptoms in rodent models and TRD in clinical studies. Previously, we have shown that sustained KOR activation leads to a TRD-like phenotype in mice, and modulation of brain-derived neurotrophic factor (BDNF) expression in the prefrontal cortex (PFC) appears to be one of the molecular determinants of the antidepressant response.

View Article and Find Full Text PDF

5-Aminolevulinic acid (ALA) is an intraoperative imaging agent approved for protoporphyrin IX (PpIX) fluorescence-guided resection of glioblastoma (GBM). It is currently under clinical evaluation for photodynamic therapy (PDT) after the completion of GBM surgery. We previously showed that lapatinib, a clinical kinase inhibitor of epidermal growth factor receptor 1 & 2 (EGFR and HER2), enhanced PpIX fluorescence in a panel of GBM cell lines by blocking ABCG2 (ATP-binding cassette super-family G member 2)-mediated PpIX efflux, which suggests its potential for improving ALA for GBM surgery and PDT.

View Article and Find Full Text PDF

Transplacental delivery of factor IX Fc-fusion protein ameliorates bleeding phenotype of newborn hemophilia B mice.

J Control Release

October 2024

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan; The Center for Advanced Medical Engineering and Informatics, Osaka University, Osaka, Japan; Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka, Japan; Laboratory of Functional Organoid for Drug Discovery, Center for Drug Discovery Resources Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Osaka, Japan. Electronic address:

Article Synopsis
  • Hemophilia B is a genetic disorder caused by a deficiency of factor IX (FIX), leading to severe bleeding issues, even starting from the fetal stage.
  • The study investigated a new method of delivering FIX to fetuses in utero using an improved adenovirus vector that creates a human FIX fusion protein, helping transport it across the placenta.
  • Results showed that newborn mice whose mothers received the treatment had significant levels of the FIX fusion protein, leading to better blood clotting abilities compared to unmodified wild-type FIX delivery.
View Article and Find Full Text PDF

Blood coagulation in Prediabetes clusters-impact on all-cause mortality in individuals undergoing coronary angiography.

Cardiovasc Diabetol

August 2024

Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.

Background: Metabolic clusters can stratify subgroups of individuals at risk for type 2 diabetes mellitus and related complications. Since obesity and insulin resistance are closely linked to alterations in hemostasis, we investigated the association between plasmatic coagulation and metabolic clusters including the impact on survival.

Methods: Utilizing data from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study, we assigned 917 participants without diabetes to prediabetes clusters, using oGTT-derived glucose and insulin, high-density lipoprotein cholesterol, triglycerides, and anthropometric data.

View Article and Find Full Text PDF

Gene therapy for people with hemophilia B: a proposed care delivery model in Italy.

J Thromb Haemost

November 2024

Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico Foundation, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. Electronic address:

Article Synopsis
  • * An Italian team of experts reviewed literature and discussed key aspects of gene therapy delivery, including team roles, patient journeys, and necessary laboratory tests during a virtual meeting.
  • * The article emphasizes the importance of a structured organizational model, multidisciplinary teamwork, and proper patient screening to ensure efficient care and follow-up in Italian hemophilia centers.
View Article and Find Full Text PDF

This tutorial describes single-step low-dimensional simultaneous inference with a focus on the availability of adjusted p values and compatible confidence intervals for more than just the usual mean value comparisons. The basic idea is, first, to use the influence of correlation on the quantile of the multivariate t-distribution: the higher the less conservative. In addition, second, the estimability of the correlation matrix using the multiple marginal models approach (mmm) using multiple models in the class of linear up to generalized linear mixed models.

View Article and Find Full Text PDF
Article Synopsis
  • Classical hemophilia A is an X-linked recessive disorder that results in a deficiency of factor VIII, leading to severe bleeding disorders, including the rare complication of spontaneous retroperitoneal hematomas.
  • A case study of a 38-year-old man with hemophilia A demonstrated a significant internal bleeding event, requiring urgent medical intervention, blood transfusions, and treatment with factor VIII and recombinant factor VIIa.
  • The case highlights that spontaneous retroperitoneal hematomas are serious emergencies in hemophilia A patients, emphasizing the importance of accurate diagnosis and careful management to prevent severe outcomes.
View Article and Find Full Text PDF

Background: Conventional adeno-associated viral (AAV) vectors, while highly effective in quiescent cells such as hepatocytes in the adult liver, confer less durable transgene expression in proliferating cells owing to episome loss. Sustained therapeutic success is therefore less likely in liver disorders requiring early intervention. We have previously developed a hybrid, dual virion approach, recombinant AAV (rAAV)/piggyBac transposon system capable of achieving stable gene transfer in proliferating hepatocytes at levels many fold above conventional AAV vectors.

View Article and Find Full Text PDF